We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Diabetes & Endocrinology

Metabolic Syndrome Increases Parkinson’s Disease Risk: Implications for Clinical Practice and Prevention

MedXY Editorial Team•Oct 5, 2025•Diabetes & Endocrinology
genetic risklifestyle interventionmetabolic syndromeParkinson's disease

Highlight

  • Individuals with metabolic syndrome have a 39% increased risk of developing Parkinson’s disease (PD) compared to those without the syndrome.
  • Genetic predisposition amplifies PD risk in patients with metabolic syndrome, with nearly double the risk observed in high-risk genotypes.
  • The PD risk increases in a dose-dependent manner according to the number of metabolic risk factors present.
  • Findings emphasize the potential of lifestyle interventions targeting metabolic health to reduce PD risk, even for genetically predisposed individuals.

Study Background and Disease Burden

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Evolving Genetic Contributions to ASD and ADHD: Insights from Diagnosis Trends (1994–2016)A Danish cohort study reveals decreased genetic risk profiles in recent ASD and ADHD diagnoses, supporting broader diagnostic criteria as a driver of rising incidence rates.Sep 24, 2026Differential Physical Activity Responses to Diabetes Risk Reduction Interventions According to Prediabetes Phenotype: Insights from Pooled Randomized Controlled TrialsThe effectiveness of lifestyle interventions promoting physical activity for diabetes risk reduction varies by prediabetes phenotype, with individuals having impaired fasting glucose showing the least response. Tailored approaches may enhanSep 17, 2026Reevaluating Levodopa’s Role in Freezing of Gait Among Parkinson’s Disease Patients: Insights from NS-Park and PPMI CohortsAnalysis of two large cohorts reveals no significant association between levodopa use and freezing of gait in Parkinson’s disease after adjusting for disease severity and duration, emphasizing the primary role of disease progression in thisSep 15, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Smoking, Exhaled Carbon Monoxide, and Parkinson’s Disease Risk: Epidemiological Insights and Mechanistic Perspectives
This review explores evidence linking smoking and exhaled carbon monoxide levels to reduced Parkinson’s disease risk, emphasizing a potential protective role of carbon monoxide, supported by recent large-scale cohort data and biologic
Sep 12, 2026
Common MC1R Variants and Parkinson Disease ProgressionThis study links MC1R loss-of-function variants to faster motor decline and phenoconversion in Parkinson’s disease, suggesting their value for prognosis and clinical trial design in European descent patients.Sep 12, 2026
Integrating Genetics and Measurable Residual Disease to Optimize Therapy in Philadelphia Chromosome-Negative Adult ALLCombining genetic risk stratification with measurable residual disease enables precise treatment allocation in adult Philadelphia chromosome-negative acute lymphoblastic leukemia, improving survival outcomes and guiding the use of allogeneiAug 25, 2026